FDA Adverse Event Injury Summary report: N

HEARTMATE II LVAS

MDR report key: 3628809 · Received January 29, 2014

Report

Report Number
2916596-2014-00102
Event Type
Injury
Date Received
January 29, 2014
Date of Event
December 30, 2013
Report Date
December 31, 2013
Manufacturer
THORATEC CORP.
Product Code
DSQ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE EXPLANTED DEVICE WAS RETURNED TO THE MFR FOR EVALUATION AND IS CURRENTLY BEING ANALYZED. NO FURTHER INFORMATION IS AVAILABLE AT THIS TIME. A SUPPLEMENTAL REPORT WILL BE SUBMITTED WHEN THE DEVICE ANALYSIS IS COMPLETED.

Description of Event or Problem · 1

THE PATIENT WAS IMPLANTED WITH A LEFT VENTRICULAR ASSIST DEVICE (LVAD). IT WAS REPORTED BY THE VAD COORDINATOR THAT THE PATIENT UNDERWENT A PUMP EXCHANGE FROM ONE LVAD TO ANOTHER LVAD DUE TO HEMOLYSIS. IT WAS ALSO REPORTED THAT OVER THE LAST SEVERAL WEEKS THE PATIENT HAS BEEN HAVING INCREASING LACTATE DEHYDROGENASE (LDH) AND PFH LEVELS. LDH TODAY APPROXIMATELY 2200, PFH 50 (DOWN FROM 90 LAST WEEK). PATIENT WITHOUT COMPLAINTS. NO URINE CHANGES OR INCREASED IN HEART FAILURE SYMPTOMS. H/H SLIGHT DROP TODAY. PER HEMATOLOGY, PATIENT STARTED ON ARIXTRA AND WILL SEE HEMATOLOGIST.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
63819 HEARTMATE II LVAS LEFT VENTRICULAR ASSIST DEVICE DSQ THORATEC CORP. 104911 117496

Patients

Seq Age Sex Outcome Treatment
1 72 YR Required Intervention